Form 4 for PLSE PULSE BIOSCIENCES, INC.
Accepted 2023-08-28 00:00:00 ET · period of report 2023-08-25 · accession 0001437749-23-024790 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-28 | 2023-08-25 | PLSE | DUGGAN ROBERT W | Dir, 10% | M - OptEx | $5.95 | +1,667 | 36.23M | +0.0% | +$9,919 |
| D | 2023-08-28 | 2023-08-25 | PLSE | DUGGAN ROBERT W | Dir, 10% | M - OptEx | $0.00 | -1,667 | 15.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-25 | M | A | 1,667 | $5.95 | 36,233,291 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2023-08-25 | M | D | 1,667 | $0.00 | 15,000 | D | $5.95 · — to 2033-05-25 | 1,667 Common Stock | (F2) Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vests on a monthly basis following the Company's last Annual Stockholder Meeting. |